DeepMed Research

The New York State Psychiatric Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1895-01-01

Employees: 251

Market Cap: -

Website: http://www.nyspi.org

Clinical Trials

A Comparison of Long-acting Injectable Medications for Schizophrenia

Phase 4

Completed

Conditions: Schizophrenia
Schizoaffective Disorder

Interventions: Drug: haloperidol decanoate
Drug: paliperidone palmitate

First Posted Date: 2010-06-03

Last Posted Date: 2016-10-21

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 311

Registration Number: NCT01136772

Locations: 🇺🇸
VA Palo Alto Heathcare Systems, Palo Alto, California, United States
🇺🇸
Medical College of Georgia, Augusta, Georgia, United States
🇺🇸
John Umstead Hospital/Duke University, Butner, North Carolina, United States

and more 19 locations

Cognitive-Motivational Behavior Therapy for Pathological Gamblers

Not Applicable

Completed

Conditions: Pathological Gambling

Interventions: Behavioral: CBT
Behavioral: CMBT

First Posted Date: 2010-06-02

Last Posted Date: 2017-03-24

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 170

Registration Number: NCT01135264

Locations: 🇺🇸
New York Psychiatric Institute, New York, New York, United States

Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: placebo
Drug: Mifepristone

First Posted Date: 2010-05-31

Last Posted Date: 2018-12-20

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 58

Registration Number: NCT01134198

Locations: 🇺🇸
STARS, New York, New York, United States

Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use Disorders

Not Applicable

Completed

Conditions: Substance Abuse

Interventions: Behavioral: Treatment-as-Usual (TAU)
Behavioral: Therapeutic Education System (TES)

First Posted Date: 2010-04-15

Last Posted Date: 2017-07-11

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 507

Registration Number: NCT01104805

Locations: 🇺🇸
Project Outreach, West Hempstead, New York, United States
🇺🇸
Willamette Family, Inc., Eugene, Oregon, United States
🇺🇸
Hina Mauka, Waipahu, Hawaii, United States

and more 7 locations

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Phase 2

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Ketamine infusion
Other: Saline

First Posted Date: 2010-04-08

Last Posted Date: 2017-02-20

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 15

Registration Number: NCT01100255

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Enhancing Attention in Adults With Compulsive Hoarding

Phase 2

Completed

Conditions: Hoarding Disorder

Interventions: Drug: Methylphenidate ER

First Posted Date: 2010-04-08

Last Posted Date: 2014-09-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 4

Registration Number: NCT01100268

Locations: 🇺🇸
Institute of Living, Hartford, Connecticut, United States
🇺🇸
New York State Psychiatric Insitute, New York, New York, United States

Psychological Symptoms Among Adolescents Enrolled in a Bariatric Surgery Program

Completed

Conditions: Obesity

First Posted Date: 2010-03-03

Last Posted Date: 2018-08-23

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 150

Registration Number: NCT01079377

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Training Clinicians in Motivational Interviewing

Not Applicable

Completed

Conditions: Substance Abuse

Interventions: Behavioral: Taped Review Supervision
Behavioral: Live teleconference supervision

First Posted Date: 2010-02-09

Last Posted Date: 2018-12-26

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 91

Registration Number: NCT01065480

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

PET Biomarkers in Treatment Resistant Depression

Phase 4

Terminated

Conditions: Major Depressive Disorder

Interventions: Drug: tranylcypromine

First Posted Date: 2009-12-15

Last Posted Date: 2014-09-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 13

Registration Number: NCT01031810

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

Dronabinol Naltrexone Treatment for Opioid Dependence

Phase 2

Completed

Conditions: Opioid Dependence

Interventions: Drug: Naltrexone and placebo
Drug: injectable naltrexone and dronabinol

First Posted Date: 2009-12-02

Last Posted Date: 2018-06-18

Lead Sponsor: New York State Psychiatric Institute

Target Recruit Count: 60

Registration Number: NCT01024335

Locations: 🇺🇸
New York State Psychiatric Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy